Trending Stories


HeartX Cardiovascular Accelerator Opens Applications for 2026 Program

Partner News | Published: Monday, February 9, 2026

The program is seeking companies in three categories: digital health and software, medical devices, and diagnostic platforms.


MedAxiom Announces Industry Partnership With Dedicated IT to Enhance Technology Strategies for Cardiovascular Organizations

Partner News | Published: Friday, February 6, 2026

Dedicated IT, a managed services provider with over two decades of experience serving healthcare organizations. This collaboration brings advanced IT support and strategic guidance to cardiovascular programs navigating increasingly complex technology demands.


Congress Passes Critical Health Program Funding, Extends Telehealth Flexibilities

News | Published: Wednesday, February 4, 2026

Congress has passed an appropriations package funding Labor, Health and Human Services, Education and Related Agencies for the remainder of fiscal year (FY) 2026. The legislation includes several high-priority provisions championed by the ACC that will strengthen cardiovascular care, support clinicians and improve patient access. The President signed the bill into law on Tuesday, Feb. 3, 2026.


MedAxiom Announces Industry Partnership With RhythMedix to Advance Remote Cardiac Monitoring

Partner News | Published: Tuesday, January 27, 2026

RhythMedix, a U.S.-based cardiac monitoring company with a fully integrated model that brings together device technology, manufacturing, software and 24/7, continuous clinical monitoring services.


MedAxiom Announces Industry Partnership With Novo Nordisk to Advance Cardiometabolic Care

Partner News | Published: Monday, January 12, 2026

Novo Nordisk, Inc., a global healthcare leader committed to transforming the management of chronic diseases, including obesity, diabetes and cardiovascular conditions.


The Year in Review: MedAxiom's Top Resources of 2025

News | Published: Friday, December 19, 2025

As we enter 2026, we reflect on an extraordinary year of progress, collaboration and transformation within the cardiovascular community. Thanks to your unwavering dedication and commitment to excellence, MedAxiom has become more than just a resource. It's a dynamic hub where knowledge is shared, ideas are sparked and innovations take root.


MedAxiom Announces Industry Partnership With Baker Donelson

Partner News | Published: Tuesday, December 16, 2025

Baker Donelson, one of the nation’s largest and most recognized healthcare law firms.


CMS Releases 2026 Hospital OPPS Final Rule

News | Published: Friday, November 21, 2025

Updated December 10, 2025
The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has finalized a 2.6% increase to OPPS payment rates that reflects a market basket update of 3.3% reduced by a productivity adjustment of 0.7%. Read about additional provisions from the final rule below.


Government Shutdown Ends With Legislation That Extends Medicare Telehealth Flexibilities

News | Published: Thursday, November 13, 2025

Congress passed legislation on Nov. 12 to fund the federal government, and shortly after, President Donald Trump signed the continuing resolution into law, ending the longest ever government shutdown after 43 days of gridlock.


Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s ASSURE Device

News | Published: Monday, November 10, 2025

Kestra Medical Technologies, Ltd., a wearable medical device and digital healthcare company, announced the primary results from the ASSURE® WCD Clinical Evaluation Post-Approval Study (ACE-PAS), presented as a Late-Breaking Science session at the American Heart Association (AHA) Scientific Sessions 2025 in New Orleans, LA. ACE-PAS, the largest prospective real-world study of wearable defibrillators (WCDs) to date, confirmed the strong safety and effectiveness of the ASSURE WCD in clinical practice.


Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.